6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Schizophrenia and Psychotic Disorders
Early detection and continuous care have become essential in managing schizophrenia and psychotic disorders, which often emerge during adolescence or early adulthood. Recent advances highlight the importance of coordinated specialty care, combining antipsychotic medication, social support, and cognitive behavioral therapy. Neuroimaging and genetic studies continue to uncover biomarkers linked to psychotic symptoms, improving diagnostic accuracy. Innovations such as digital monitoring tools and long-acting injectable medications enhance treatment adherence and functional outcomes. Psychosocial rehabilitation remains a cornerstone, helping individuals build life skills, re-enter the workforce, and maintain meaningful relationships. Integrating neuroscience, clinical care, and social services offers a more holistic approach to sustained recovery.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States